Thank you, Mr. Chair.
Ms. Drouin, what regulatory barriers could the federal government remove to simplify the process; to ensure that health authorities and community agencies can apply for and receive exemptions; and to provide supervised consumption, overdose prevention and drug analysis services? Above all, why should these barriers be removed?